Kienzle N, Bröker M, Harthus H P, Enders M, Erfle V, Buck M, Müller-Lantzsch N
Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Homburg, Federal Republic of Germany.
Arch Virol. 1991;118(1-2):29-41. doi: 10.1007/BF01311301.
We constructed and expressed different overlapping fusion proteins with the nef gene of HIV-1 and generated specific polyclonal rabbit and monoclonal mouse antibodies against these recombinant proteins. The rabbit antisera, one of the monoclonal antibodies as well as a serum from a HIV-1 infected patient recognized the nef protein with Mr 27 kDa in latently HIV-1 infected glioma cells in the immunoblot. In contrast, these antibodies could not detect nef in productively HIV-1 infected Molt-3 cells neither in immunoblot nor in indirect immunofluorescence assays. These results indicate the possible participation of nef in viral latency. The recombinant nef proteins were used as probes for anti-nef antibodies in human sera. We observed in 17 of 57 sera tested specific anti-nef antibodies. All of these anti-nef positive sera also contained antibodies directed against viral structural proteins. The NH2-terminal region of the recombinant nef was shown to be the major immunodominant antigenic site in the immunoblot assay.
我们构建并表达了与HIV-1的nef基因不同的重叠融合蛋白,并针对这些重组蛋白产生了特异性的兔多克隆抗体和小鼠单克隆抗体。兔抗血清、其中一种单克隆抗体以及一名HIV-1感染患者的血清在免疫印迹中识别潜伏感染HIV-1的胶质瘤细胞中分子量为27 kDa的nef蛋白。相比之下,这些抗体在免疫印迹和间接免疫荧光试验中均无法检测到高效感染HIV-1的Molt-3细胞中的nef。这些结果表明nef可能参与病毒潜伏。重组nef蛋白用作人血清中抗nef抗体的探针。我们在57份检测血清中的17份中观察到特异性抗nef抗体。所有这些抗nef阳性血清也含有针对病毒结构蛋白的抗体。在免疫印迹试验中,重组nef的NH2末端区域显示为主要的免疫显性抗原位点。